Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

NCT00093444 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Liver Cancer
Metastatic Cancer

Interventions

DRUG: lyso-thermosensitive liposomal doxorubicin
PROCEDURE: radiofrequency ablation

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]